Blaze Medical Devices, Inc.
Biotechnology ResearchMichigan, United States2-10 Employees
Blaze Medical Devices, Inc. is a biotechnology research company based in Ann Arbor, Michigan. It developed technology to profile the mechanical fragility of red blood cells, aiming to characterize RBC health and damage across different contexts. In 2018 the company licensed its intellectual property to Detroit-based Functional Fluidics, which began offering an RBC mechanical fragility test alongside its existing assays. Since the licensing, Blaze’s ongoing IP oversight has been managed by its board members, who are responsible for guiding the arrangement and any related developments. The firm operates within the biotechnology research sector and maintains a relatively small organizational footprint. Its work targets customers and collaborators involved in red blood cell analysis and related diagnostic applications, seeking objective measures of RBC integrity to inform research or clinical contexts. Blaze’s current activity appears to be focused on IP management and licensing, with a recent development involving the transfer of its technology into a commercial product through Functional Fluidics.